BRAF and cancer: The five miRNAs—miR-192, miR-30D, hsa-miR-16-5p, miR-143-3p, and miR-20a-5p—were selected based on their predicted targeting of key prognostic genes (TIMP3, BRAF, and ITGB1); enrichment pathway analysis implicating them in cancer-relevant signaling pathways.